Remove tag language
article thumbnail

CRISPR tagging improves accuracy of model cells grown from stem cells

Scienmag

Tagging produces detailed catalog of transcription factors key to making each cell type Credit: Gersbach Lab, Duke University DURHAM, N.C. – A team of biomedical engineers at Duke University has created a new way to turn stem cells into a desired cell type by mastering the language of gene regulatory networks.

article thumbnail

A look back at the “Joint-efforts for pathogen genomics in public health surveillance” symposium

Sciensano

BE READY project coordinator, Transversal activities in Applied Genomics ( TAG )). Dr. Marie-Alice Fraiture ( TAG ). Dr. Sigrid De Keersmaecker ( TAG ). Dr. Kevin Vanneste ( TAG ). BE READY project, but it is only the beginning for the collaborations and innovations that have been fostered. The organization comitee.

Genome 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Grand Rounds December 8, 2023: A Pragmatic Randomized Trial of the Jumpstart Intervention to Promote Communication about Goals of Care for Hospitalized Patients with Serious Illness (Ruth Engelberg, PhD; Erin Kross, MD; Robert Lee, MD, MS)

Rethinking Clinical Trials

The goals of care discussions were identified by a natural language processing (NLP) called BERT and screened human abstraction. The key thing with these models is that they have gotten bigger to accommodate the language. We could possibly take out the training phase. – What is the concern about prompt fatigue in these settings?

Trials 130
article thumbnail

Grand Rounds February 2, 2024: Strategies for Improving Public Understanding of FDA and the Products It Regulates…Why Should We Care, and What Might We Do? (Susan C. Winckler, RPh, Esq)

Rethinking Clinical Trials

Potential strategies: Adopt a consistent, fact-based tone; use concise, digestible, plain-language approaches; use storytelling and personal narratives. Potential strategies: “Prebunk” health misinformation; collaborate with other organizations (within and beyond government); monitor and respond to misunderstandings.

article thumbnail

Grand Rounds February 16, 2024: Clinical Implications of the MINT Trial: p=0.07 (Jeffrey Carson, MD, MACP)

Rethinking Clinical Trials

One of our reviewers was incredibly helpful in helping us frame the relative risk confidence interval concepts that I described, which helped us shape the language. I think that the journal bought into that and helped us do it. It wound up being a very collaborative, constructive process.

Trials 130
article thumbnail

Grand Rounds August 12, 2022: Equitably Including Diverse Participants in Pragmatic Clinical Trials (Consuelo H. Wilkins, MD, MSCI)

Rethinking Clinical Trials

There is a need to shift our language. Because the system and structures have not been built equitability, we will need to invest more and have more transparency and accountability at every level, from the investigator, funder, publisher and journals. It is everyone’s responsibility. How we categorize race and ethnicity in the U.S.

article thumbnail

What can pharma marketing learn from other regulated industries?

pharmaphorum

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Joanna Carlish, managing director, financial services, Tag Americas. Virtual connections.